BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36245969)

  • 1. Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma.
    Liu X; Fu M; Xia D; Ji Z; Hu N; Leng Z; Xie W; Fang Y; Zhang J
    J Oncol; 2022; 2022():8767333. PubMed ID: 36245969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
    Zhang J; Sun G; Mei X
    Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
    Zhang JT; Lin YC; Xiao BF; Yu BT
    Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma.
    Wang G; Li X; Yao Y; Jiang Z; Zhou H; Xie K; Luo J; Shen Y
    Oncol Lett; 2021 Apr; 21(4):297. PubMed ID: 33732373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma.
    Fei W; Yan Y; Liu G; Peng B; Liu Y; Chen Q
    PeerJ; 2023; 11():e16306. PubMed ID: 37904848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G; Wang P; Zheng X; Liu D; Sun X
    Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma.
    Zhou F; Wang X; Liu F; Meng Q; Yu Y
    Int J Clin Oncol; 2020 Sep; 25(9):1612-1623. PubMed ID: 32430734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
    Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
    Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Yu J; Hou M; Pei T
    DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAM83A promotes the progression and metastasis of human pancreatic neuroendocrine tumors by inducing the epithelial-mesenchymal transition via the PI3K/AKT and ERK pathways.
    Zhou B; Zhou X; Zhan C; Jin M; Yan S
    J Endocrinol Invest; 2023 Jun; 46(6):1115-1130. PubMed ID: 36344884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis.
    Zheng YW; Li ZH; Lei L; Liu CC; Wang Z; Fei LR; Yang MQ; Huang WJ; Xu HT
    Front Oncol; 2020; 10():180. PubMed ID: 32195172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma.
    Zhang M; Huo C; Jiang Y; Liu J; Yang Y; Yin Y; Qu Y
    J Cancer; 2021; 12(6):1742-1754. PubMed ID: 33613763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM83A Promotes the Proliferative and Invasive Abilities of Cervical Cancer Cells via Epithelial-Mesenchymal Transition and the Wnt Signaling Pathway.
    Lan C; Liu CC; Nie XC; Lei L; Xiao ZX; Li MX; Tang XN; Jia MY; Xu HT
    J Cancer; 2021; 12(21):6320-6329. PubMed ID: 34659522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
    Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
    Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC.
    Zhou F; Geng J; Xu S; Meng Q; Chen K; Liu F; Yang F; Pan B; Yu Y
    Aging (Albany NY); 2019 Aug; 11(16):6069-6088. PubMed ID: 31444970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
    Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
    Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
    [No Abstract]   [Full Text] [Related]  

  • 18. LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A.
    Wang W; Zhao Z; Xu C; Li C; Ding C; Chen J; Chen T; Zhao J
    Thorac Cancer; 2021 May; 12(10):1495-1502. PubMed ID: 33687144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family with sequence similarity 83 member A promotes tumor cell proliferation and metastasis and predicts poor prognosis in cervical cancer.
    Liu T; Chen J; Du Q; Liu J; Chen M; Ooi S; Huang J; Wang W; Yao S
    Pathol Res Pract; 2021 Jun; 222():153450. PubMed ID: 33962175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of MicroRNA-1-FAM83A Axis Dysfunction in the Growth and Motility of Lung Cancer Cells.
    Liu PJ; Chen YH; Tsai KW; Yeah HY; Yeh CY; Tu YT; Yang CY
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.